Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies
异基因嵌合抗原受体T细胞产品Cemacabtagene Ansegedleucel/ALLO-501治疗复发/难治性大B细胞淋巴瘤:ALPHA2/ALPHA临床研究的I期经验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01933
Locke, Frederick L; Munoz, Javier L; Tees, Michael T; Lekakis, Lazaros J; de Vos, Sven; Nath, Rajneesh; Stevens, Don A; Malik, Shahbaz A; Shouse, Geoffrey P; Hamadani, Mehdi; Oluwole, Olalekan O; Perales, Miguel-Angel; Miklos, David B; Fisher, Paul W; Feng, Amy; Navale, Lynn; Le Gall, John B; Neelapu, Sattva S
B细胞
T细胞
信号转导
淋巴瘤
T细胞
细胞生物学
免疫/内分泌